19 May 2013
Keywords: ribozyme, pharma, pharmacia, biotech, compound, development, deal
Article | 29 January 1996
Ribozyme Pharmaceuticals has joined with Pharmacia Biotech for the development of cost-effective methods of synthesizing amidites, the core molecular species ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.